Citation: J. Kinsey et al., TIME-DEPENDENT SCENARIO MODELING OF THE TOKAMAK PHYSICS EXPERIMENT USING A THEORY-BASED TRANSPORT MODEL, Physics of plasmas, 3(3), 1996, pp. 1064-1072
Authors:
KRITZ A
READ J
ELY P
CORNELL C
MILLS L
BRIGHTON S
STEARNS D
ROACH M
LOWREY C
Citation: A. Kritz et al., USE OF PERIPHERAL-BLOOD PROGENITORS (PBP) TO ALLOW HIGH-DOSE ARA-C (HDAC) CONSOLIDATION CYCLES IN ELDERLY PTS WITH AML, Blood, 88(10), 1996, pp. 3862-3862
Authors:
RATHMANN J
LAM G
HERMANN D
ELY P
LOWREY C
MILLS L
BRIGHTON S
STEARNS D
ROACH M
KRITZ A
Citation: J. Rathmann et al., SUCCESSFUL SALVAGE OF PTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE (RR-HD) WITH BEC FOLLOWED BY AUTOLOGOUS CELL TRANSPLANT (ACT), Blood, 88(10), 1996, pp. 3873-3873
Authors:
ELY P
LI O
LOWREY C
KRITZ A
HERMANN D
MILLS L
Citation: P. Ely et al., PRESENCE OF HER-2 NEU POSITIVE CELLS BY RT-PCR IN BONE-MARROW HARVESTS OF PATIENTS UNDERGOING BONE-MARROW TRANSPLANT FOR BREAST-CANCER DOESNOT PREDICT RELAPSE/, Blood, 88(10), 1996, pp. 499-499
Authors:
MILLS LE
ELY P
ERICSON SG
LI O
FOSTER C
KRITZ A
LARSEN E
LOWREY C
AUBUCHON J
STEARNS D
BRIGHTON S
ROACH M
HERMANN D
Citation: Le. Mills et al., HYPERFIBRINOGENEMIA WITH GELLING IN COLLECTION BAGS IS DOSE-LIMITING FOR STEM-CELL COLLECTIONS PRIMED WITH IL-6 AND G-CSF - A PHASE-1 STUDYOF AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT), Blood, 86(10), 1995, pp. 2319-2319
Authors:
ELY P
LOWREY C
MILLS L
HERMANN D
STEARNS D
BRIGHTON S
ROACH M
HARJES J
MOTT L
LAMM G
KRITZ A
Citation: P. Ely et al., HIGH-DOSE CHEMOTHERAPY WITH BVAC REGIMEN, AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND PRIMED PERIPHERAL-BLOOD STEM-CELLS YIELDS DURABLE REMISSIONS WITHOUT EXCESSIVE TOXICITY IN NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 3764-3764
Authors:
KRITZ A
BENOIT N
ELY P
LOWREY C
MILLS L
HERMANN D
BRIGHTON S
STEARNS D
ERICSON S
Citation: A. Kritz et al., MULTIPLE ROUNDS OF MYELOABLATIVE CHEMOTHERAPY RESULT IN IMPAIRED ENGRAFTMENT WITH PROBABLE STROMAL DAMAGE, Blood, 86(10), 1995, pp. 3799-3799
Authors:
SCHNEIDER JG
CROWN JP
WASSERHEIT C
KRITZ A
WONG G
REICH L
NORTON L
MOORE MAS
Citation: Jg. Schneider et al., FACTORS AFFECTING THE MOBILIZATION OF PRIMITIVE AND COMMITTED HEMATOPOIETIC PROGENITORS INTO THE PERIPHERAL-BLOOD OF CANCER-PATIENTS, Bone marrow transplantation, 14(6), 1994, pp. 877-884
Citation: C. Chen et A. Kritz, REPORT OF INADVERTENT USE OF ANAGRELIDE DURING THE 1ST TRIMESTER OF PREGNANCY IN A PATIENT WITH ESSENTIAL THROMBOCYTOSIS, Blood, 84(10), 1994, pp. 10000630-10000630
Authors:
WEISS M
TELFORD P
KEMPIN S
KRITZ A
SOGOLOFF H
GEE T
BERMAN E
SCHEINBERG D
LITTLE C
GAYNOR J
BELANGER C
BERTINO J
ANDREEFF M
MCKENZIE S
CLARKSON B
Citation: M. Weiss et al., SEVERE TOXICITY LIMITS INTENSIFICATION OF INDUCTION THERAPY FOR ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 7(6), 1993, pp. 832-837
Authors:
CROWN J
KRITZ A
VAHDAT L
REICH L
MOORE M
HAMILTON N
SCHNEIDER J
HARRISON M
GILEWSKI T
HUDIS C
GULATI S
NORTON L
Citation: J. Crown et al., RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVECHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1144-1149
Authors:
KRITZ A
SANTANSIERI V
RODRIGUEZ E
JAKUBOWSKI A
REUTER V
OFFIT K
BOSL G
Citation: A. Kritz et al., THE ASSOCIATION OF A T-CELL LYMPHOMA AND MEDIASTINAL GERM-CELL TUMOR (MGCT) IN CONJUNCTION WITH FATAL REACTIVE HEMATOPHAGOCYTOSIS, ELEVATEDGM-CSF AND M-CSF LEVELS, Blood, 82(10), 1993, pp. 10000570-10000570